Applications are evaluated based on four criteria:
- Scientific merit
- Innovation
- Clinical and medical impact
- Quality of research environment:
![](/documents/518439/553039/ico_scientific_merit.png/d8b4521f-af76-44b3-9030-8aad8be45041?t=1477304177744)
Scientific merit
- The validity of the rationale / proposed methodology
- The validity of the expected outcomes
- The validity of the proposed timelines
- The feasibility of completing the proposed work within 24 months
![](/documents/518439/553039/ico_innovation.png/fdc0d31d-d861-4ed0-a13e-9459bdb6f91c?t=1477304165141)
Innovation
- Innovation in design, methodology and objectives
![](/documents/518439/553039/ico_clinical.png/38aad32c-f7b7-4f62-a3e1-407b44eeeb1c?t=1477304158577)
Clinical / medical impact
- Contribution of the project results to clinical and scientific understanding
- Relevance of the project to the immunodeficiency disease community
![](/documents/518439/553039/ico_research.png/7a490e3f-2d56-4167-b048-7105e8639c64?t=1477304171585)
QUALITY OF RESEARCH ENVIROMENT
- Mentor's and/or applicant's research focus, clinical/scientific expertise and experience
- Qualification of the applicant
- Expertise in the academic research environment